China-Biotics, Inc. to Present at Roth 2007 New York Conference
The Roth Capital Partners 2007 New York Conference is a two-day eventfeaturing presentations and one-on-one meetings with more than 230 growthcompanies in a variety of industries.
About China-Biotics, Inc.
Headquartered in Shanghai, China-Biotics, Inc. ("China-Biotics", "theCompany") was founded in 1999 and is one of China's largest suppliers ofprobiotics. Probiotics are beneficial live bacteria used as dietarysupplements and food additives to improve intestinal health and digestion. TheCompany's product portfolio contains live microbes made with proprietarytechnology. Currently, these products are sold over-the-counter under the"Shining" brand through large distributors to more than 1,000 pharmacies and100 supermarkets in Shanghai, Jiangsu and Zhejiang. Shining is one of the mostrecognized brands in Shanghai. China-Biotics plans to expand its retail salesto other major cities in China and will launch 300 Shining brand logisticcenters in these cities during the next two years. The Company's flagshipproduct, "Shining Essence," has been a profit driver since its launch in April2001. There is a significant demand for probiotics for use in the bulkadditive market, which is currently met by imports. China-Biotics is buildinga new plant which will increase its production capacity manifolds to capturethis market.
Safe Harbor Statement Under the Private Securities Litigation Reform Actof 1995: Any statements set forth above that are not historical facts areforward-looking statements that involve risks and uncertainties that couldcause actual results to differ materially from those in theforward-looking statements. Such factors include, but are not limited to, theCompany's ability to market existing and new products, ability to accesscapital for expansion, changes from anticipated levels of sales, futurenational or regional economic and competitive conditions, completion of theabove mentioned contract with Bright Dairy, changes in relationships withcustomers, dependence on its flagship product profits and other factorsdetailed from time to time in the Company's filings with the United StatesSecurities and Exchange Commission and other regulatory authorities. TheCompany undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events orotherwise.Date: Thursday, September 6, 2007 Time: 1:30 p.m. EDT Venue: The Westin New York at Times Square
SOURCE China-Biotics, Inc.
You May Also Like